citalopram has been researched along with dalteparin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Francis, L; Jackson, K; Kennedy, GA; May, C; O'Rourke, K | 1 |
Audley, GG; Cairncross, L; Calligaro, G; Dlamini, S; Frankenfeld, P; Gule, MV; Hoare, J; Raubenheimer, P; Van den Berg, R | 1 |
2 other study(ies) available for citalopram and dalteparin
Article | Year |
---|---|
Purpura fulminans in a patient with paroxysmal nocturnal haemoglobinuria.
Topics: Amoxicillin; Anticoagulants; Blood Coagulation Tests; Citalopram; Contraindications; Drug Therapy, Combination; Enoxaparin; Hemoglobinuria, Paroxysmal; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasma; Platelet Transfusion; Prednisolone; Prednisone; Protein C Deficiency; Purpura Fulminans; Remission Induction; Virus Diseases; Vitamin K; Warfarin; Young Adult | 2013 |
Prolonged treatment of COVID-19 pneumonia with high-flow nasal oxygen: A story of oxygen and resilience.
Topics: Anti-Bacterial Agents; Anticoagulants; Anxiety; Blood Gas Analysis; Cannula; Citalopram; Counseling; COVID-19; Dexamethasone; Disease Progression; Enoxaparin; Factor Xa Inhibitors; Female; Glucocorticoids; Healthcare-Associated Pneumonia; Hematoma; Humans; Hypoxia; Middle Aged; Oxygen; Oxygen Inhalation Therapy; Patient Care Team; Patient Positioning; Piperacillin, Tazobactam Drug Combination; Prone Position; Psychiatry; Psychosocial Support Systems; Resilience, Psychological; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Social Work Department, Hospital; Thigh; Treatment Outcome | 2020 |